In Utero Development of Neonatal Cutaneous Lupus  by Won, Sau-Pin et al.
Taiwan J Obstet Gynecol • March 2009 • Vol 48 • No 1 79
■ RESEARCH LETTER ■
Neonatal lupus erythematosus (NLE) is characterized by
cutaneous lupus, isolated congenital heart block (CHB),
and a variety of systemic and hematologic abnormali-
ties. The incidence of NLE is about 5–10% in mothers
with systemic lupus erythematosus (SLE) [1]. Neonatal
cutaneous lupus is a benign and self-limiting condition
when it presents in isolation. The presence of anti-Ro
autoantibodies in the affected infant’s serum correlates
with disease activity in the skin. The disease activity
generally resolves by about the age of 6 months as the
antibody titer decreases [2]. The mean time of detec-
tion of the skin rash ranges from birth to 20 weeks
postpartum with a mean age at detection of 6 weeks.
The rash is often exacerbated after exposure to UV
light. In previous reports, only a minority (16–23%) of
infants were found to have the rash at birth [2,3]. We
report here a female baby who was born to an SLE
mother with positive anti-Ro and anti-La; the baby
already had an extensive skin rash at birth, suggesting
that sun exposure was not a requirement for these 
skin lesions.
A woman aged 32 years, gravida 3, para 2, gave
birth to a female baby with an extensive skin rash. The
delivery was by cesarean section at 39+6 weeks of preg-
nancy because of breech presentation. The patient had
been in good health until she was aged 31 years when,
3 months before this pregnancy, she developed a malar
rash. An evaluation at a hospital led to the diagnosis of
SLE. Low-dose prednisolone was administered but was
discontinued by the patient herself after the pregnancy
was diagnosed. Her obstetric history consisted of two
normal spontaneous vaginal deliveries. Both female
babies were normal. She had no other medical or sur-
gical history, and did not take any medications after the
pregnancy was detected. The whole course of the preg-
nancy was uneventful. There was no skin rash, arthralgia
or myalgia during the pregnancy. An antenatal sonog-
raphy at 20 weeks of pregnancy revealed no fetal cardiac
arrhythmia. Her prenatal screening test for antibodies
to rubella was positive and tests for syphilis and hepa-
titis B surface antigen were negative. Her laboratory tests
at 39+6 weeks of pregnancy showed positivity for anti-
nuclear antibodies (ANA) (1/2,560, speckled pattern),
anti-Ro (1/575) and anti-La (1/721), but were negative
for anti-ribonucleoprotein (RNP) and anti-Sm.
The female infant had a birth weight of 2,660 g, 
an Apgar score of 8 at 1 minute and 9 at 5 minutes.
Meconium staining and an extensive skin rash were
noted at birth. Widespread geographic erythematous
annular and scaly plaques occurred over the face, scalp,
trunk and legs, and were most marked on the face. The
spectacle-like erythemas around her eyes gave a “mask”
or “owl’s eye”-like appearance (Figure 1). Some pete-
chiae were displayed in her inguinal areas. A geo-
graphic erythematous plaque was seen over the left
upper abdomen (Figure 2). There was no involvement
of the conjunctiva or the vaginal mucosae. A 12-lead
electrocardiogram showed a normal sinus rhythm and
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Figure 1. Spectacle-like erythemas around the eyes, giving 
a “mask” or “owl’s eye” appearance.
echocardiography was also normal. Laboratory testing
showed mild anemia (hemoglobin, 12.6 g/dL; hemat-
ocrit, 39.4%), moderate thrombocytopenia (34,000/
mm3) and mildly elevated liver enzymes (aspartate
aminotransferase, 72 U/L). The blood coagulation stud-
ies were within normal limits. Serum tests gave a posi-
tive result for cytomegalovirus (CMV) IgG, but were
negative for CMV IgM and herpes simplex virus type II
IgG and IgM. An autoantibody profile showed positivity
for ANA (1/1,280), anti-Ro (1/240) and anti-La (1/320),
and negativity for anti-ds DNA, anti-cardiolipin and
anti-phospholipid antibodies. A urine specimen was
positive for group B streptococci antigen.
The infant was admitted to the intensive care unit
because of progressive respiratory distress and moderate
thrombocytopenia where she was treated with anti-
biotics and nasal continuous positive airway pressure
ventilation support. Her condition became stable and
no new skin lesions appeared; she was discharged 12
days after birth. Nearly all skin lesions had sponta-
neously faded by the age of 4 months.
SLE is a multisystemic disease involving the produc-
tion of several autoantibodies, followed by immune
complex formation and deposition with consequential
clinical manifestations. Sunlight (UV light) exacerbates
the disease, because UV light results in the crosslinking
of DNA in cells. The release of DNA in an immunogenic
form (UV crosslinked) can lead to autoimmunization.
Pregnant woman with SLE have been shown to have
an increased risk of fetal wastage, preterm birth, intra-
uterine growth restriction, and NLE [4].
Neonatal cutaneous lupus is a benign condition that
develops in 5% of babies of mothers who may have
SLE, Sjögren syndrome, or who may be entirely asymp-
tomatic but with anti-Ro and anti-La autoantibodies.
Neonatal cutaneous lupus frequently occurs during
the second and third month of life, manifesting as a
typical periorbital skin rash (mask or owl’s eye appear-
ance), when the baby is exposed to the UV present in
sunlight and there is externalization of the intranuclear
autoantigens at the cell surface. Female infants are
more commonly affected, and this is attributed to in-
creased anti-Ro expression by keratinocytes in response
to estrogen [5].
In two previous large series studying neonatal cuta-
neous lupus, it was revealed that only a minority of
cases, 16% and 23%, presented with a skin rash at birth
[2,3]. In the report by Neiman et al [3], the mean age
of appearance was 6 weeks and, in general, UV expo-
sure is thought to be an initiating factor. Cimaz et al
[6] reported a female infant born to an anti-Ro and
anti-La negative, but anti-RNP positive mother, whose
baby presented with an extensive NLE rash at birth. The
authors suggested that sun exposure is not a require-
ment for the development of an NLE skin rash.
Differential diagnoses include intrauterine infection
with CMV, intrauterine infection with group B strepto-
cocci, and noninfectious dermatoses of the neonate,
such as erythema marginatum, urticaria, tinea corpus,
erythema annulare centrifugum and erythema multiform.
The most common clinical manifestations of congeni-
tal CMV infection are hepatosplenomegaly, intracranial
calcifications, jaundice, growth restriction, microceph-
aly, chorioretinitis, and hearing loss. The skin lesions are
vesicular, but they are rare and present only at birth.
Thus in this case, congenital CMV infection was not
likely. The reported skin lesions of the neonatal group
B streptococci infection include vesicles, bulla, crusts
and erosions, which were not seen in this case.
Erythema marginatum is the presence of pink rings
on the trunk and inner surfaces of the arms and legs.
The rings are barely raised, and the face is generally
spared. Urticaria (wheals or hives) is characterized by
elevated lesions caused by localized edema. Wheals are
a common manifestation of hypersensitivity to drugs,
stings/bites and autoimmunity. Tinea corpus is a fun-
gal infection that manifests as multiple scaly patches
varying in color from white to brown. Erythema annu-
lare centrifugum appears as a raised pink-red ring or
bull’s eye marks, ranging in size from 0.5 cm to 8 cm.
The erythema annulare centrifugum lesions are usually
located on the buttocks, thighs and upper arms, and last
for months or years. Erythema multiforme is character-
ized by target or iris skin lesions, and the oral mucosa
may be involved. The classic lesion of erythema multi-
forme is annular, with a violaceous center and pink halo
separated by a pale ring; the distribution is symmetric
and centripetal. All the above cutaneous abnormalities
were absent in our patient.
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Figure 2. A geographic erythematous plaque over the
abdomen.
Meconium aspiration may have occurred with this
full-term breech baby and may have been one of the
causes of the respiratory distress syndrome after birth.
Iatrogenic respiratory distress syndrome in newborns
occurs even after cesarean section at 39 weeks of ges-
tation with an absolute risk of 0.4% [7]. Neonates with
congenital pneumonia also present with respiratory
distress syndrome symptoms from very early in life.
There is a tendency for the subsequent pregnancies
of women with autoantibodies to result in the birth of
children with NLE. In the series of Neiman et al [3], the
risk of CHB with or without rash in a subsequent birth
was 30%. In 1999, Shinohara et al [8] administered
betamethasone to mothers with SLE before 16 weeks’
gestation and none of 26 neonates demonstrated CHB,
whereas 15 of 61 neonates whose mothers received no
corticosteroids or had begun receiving steroid therapy
after 16 weeks’ gestation showed CHB. The cause of
CHB is presumed to be a widespread inflammatory
response in the conduction system of the fetal heart
caused by the transplacental maternal autoantibodies.
The sinus node can be recognized in the first trimester,
and the conduction system reaches functional maturity
by week 16 of gestation. However, complete CHB once
established is irreversible, and prenatal maintenance
therapy with betamethasone given to the mother start-
ing before 16 weeks’ gestation would seem to reduce
the risk of CHB in the offspring. Maternal corticosteroid
therapy, however, does not seem to effectively prevent
cutaneous lupus erythematosus [8]. The true incidence
of NLE is not known, but Boh [9] estimated the rate as
1 in every 12,500 live births.
About half of the NLE babies have cutaneous lupus
and the other half have CHB, with 10% having both [9].
CHB is a potentially fatal complication, and as a pace-
maker is required in many cases, it is worthwhile coun-
seling the SLE mother about the risk of CHB. All babies
with NLE should be examined for CHB and later checked
for the development of a rheumatic disease.
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